Analyst Upgrades

• SunTrust upgraded Anadarko Petroleum (APC) to buy from neutral. The firm believes weakness related to the oil spill disaster is overdone and is a buying opportunity. The firm set an $82 price target on the stock.
• JPMorgan upgraded NII Holdings (NIHD) to overweight from neutral following the company's Q1 results. The firm has a $55 price target on the stock.
• Keefe Bruyette upgraded Columbia Banking (COLB) to outperform from market perform following the company's secondary offering due to valuation. The firm has a $30 price target on the stock.
• Clean Harbors (CLH) was upgraded to outperform from neutral at Credit Suisse.
• Pinnacle Entertainment (PNK) was upgraded to buy from neutral at Janney Montgomery.
• Digital River (DRIV) was upgraded to overweight from equal weight at First Analysis.

Continue reading Analyst Calls: APC, BP, COLB, GS, IGTE, MCD, MLM, MXL, NIHD, SRDX ...

Analyst Calls: APC, BP, COLB, GS, IGTE, MCD, MLM, MXL, NIHD, SRDX ... originally appeared on BloggingStocks on Mon, 03 May 2010 11:40:00 EST. Please see our terms for use of feeds.

Continue reading Closing Bell: Market surges after yo-yo session; WM and AIG up, SRDX, CPST, STT all down

Closing Bell: Market surges after yo-yo session; WM and AIG up, SRDX, CPST, STT all down originally appeared on BloggingStocks on Thu, 18 Sep 2008 16:20:00 EST. Please see our terms for use of feeds.

The NEXT company in my ongoing series of the top 25 stocks for the NEXT 25 years is SurModics, Inc. (NASDAQ: SRDX). This Eden Prairie, Minnesota-based company has a current market capitalization of $650 million with a revenue run rate of $75 million. The company is actively involved in many next-generation medical technologies.

SurModics' mission is to provide leading-edge surface modifications and advanced drug delivery technologies and products. The company is divided into three distinct divisions: drug delivery, hydrophillic and In-Vitro. The drug delivery segment offers various technologies to site-specific delivery of drugs. Within this segment is the burgeoning ophthalmology division, which helps deal with serious eye diseases such as age-related macular degeneration. The hydrophillic segment has proprietary technologies for medical devices. It's a lubricious coating that allows for better placement and maneuverability of the actual devices. The In-Vitro division includes products for genomic slide technologies and stabilization products for immunoassay diagnostic testing.

SurModics sells its products to a whole host of medical device and life sciences companies. The hydrophillic business segment will normally have a very long term commitment with its medical device customer, as SurModic will specifically formulate the lubricant to compliment the device company's requirements to satisfy the US Food and Drug Administration (FDA). The same with the two other divisions as SurModics is usually involved early on in the development and FDA approval process.

Continue reading The top 25 stocks for the NEXT 25 years: SurModics

The top 25 stocks for the NEXT 25 years: SurModics originally appeared on BloggingStocks on Mon, 11 Jun 2007 13:27:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Wedbush initiated CKE Restaurants (NYSE: CKR) with a Buy rating and $25 target.

• Wachovia resumed coverage of Texas Instruments Inc (NYSE: TXN) with an Outperform rating, as the firm believes that TXN's fundamentals have bottomed and the valuation is attractive.

• SurModics Inc (NASDAQ: SRDX) was initiated with an Underperform rating and $28 target at Piper Jaffray. Piper doesn't see a near-term catalyst to move shares higher given a lack of visibility regarding new licenses.

• Nokia (NYSE: NOK) was initiated at Nollenberger with a Neutral rating.

• HSBC started DirecTV (NYSE: DTV) with an Underweight rating and $21 target.

• Stanford initiated Armor Holdings, Inc (NYSE: AH) with a Buy rating and $80 target.

• Wedbush initiated Jack in the Box Inc (NYSE: JBX) with a Hold rating and $68 target, citing the company's operational improvements and benefits from ongoing refranchising and share repurchases are fully reflected in the stock price.

• Canadian Pacific Railway Ltd (NYSE: CP) was initiated with a Sector Performer rating at CIBC.

• Stifel initiated Medical Properties Trust, Inc (NYSE: MPW) with a Hold rating.

• Bear Stearns initiated Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) with a Peer Perform rating.

• Thomas Wiesel initiated shares of Cepheid (NASDAQ: CPHD) and Luninex Corp (NASDAQ: LMNX) with Overweight ratings.

Analyst initiations 3-20-07: Nokia, Teva Pharma & Texas Insturments initiated today originally appeared on BloggingStocks on Tue, 20 Mar 2007 11:21:00 EST. Please see our terms for use of feeds.